The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers

Abstract. The effects of capsules containing 60 mg of a standardised extract of Ginkgo biloba (GK501) and 100 mg of a standardised extract of Panax ginseng (G115) on various aspects of cognitive function were assessed in healthy middle-aged volunteers. A double blind, placebo controlled, 14 week, parallel group, repeated assessment, multi-centre trial of two dosing regimens, 160 mg b.i.d. and 320 mg o.d. was conducted. Two hundred and fifty-six healthy middle-aged volunteers successfully completed the study. On various study days (weeks 0, 4, 8, 12 and 14) the volunteers performed a selection of tests of attention and memory from the Cognitive Drug Research computerised cognitive assessment system prior to morning dosing and again, at 1, 3 and 6 h later. The volunteers also completed questionnaires about mood states, quality of life and sleep quality. The Ginkgo/ginseng combination was found significantly to improve an Index of Memory Quality, supporting a previous finding with the compound. This effect represented an average improvement of 7.5% and reflected improvements to a number of different aspects of memory, including working and long-term memory. This enhancement to memory was seen throughout the 12-week dosing period and also after a 2-week washout. This represents the first substantial demonstration of improvements to the memory of healthy middle-aged volunteers produced by a phytopharmaceutical.

[1]  V. Petkov,et al.  Memory Effects of Standardized Extracts of Panax ginseng (G115), Ginkgo biloba (GK 501) and their Combination Gincosan® (PHL-00701) , 1993, Planta medica.

[2]  J. Kaye,et al.  The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. , 1998, Archives of neurology.

[3]  K. Wesnes,et al.  The effects of moclobemide on cognition. , 1989, Journal of neural transmission. Supplementum.

[4]  L. Christmas,et al.  Effects of temazepam premedication on cognitive recovery following alfentanil-propofol anaesthesia. , 1989, British journal of anaesthesia.

[5]  M. Marcoli,et al.  A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. , 1986, Journal of ethnopharmacology.

[6]  B W Ellis,et al.  The St. Mary's Hospital sleep questionnaire: a study of reliability. , 1981, Sleep.

[7]  V. Petkov,et al.  Participation of the serotonergic system in the memory effects of Ginkgo biloba L. and Panax ginseng C. A. Mey , 1994 .

[8]  J. Kleijnen,et al.  GINKGO BILOBA DRUG PROFILE , 1992 .

[9]  W. Herrmann,et al.  Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. , 1996, Pharmacopsychiatry.

[10]  R. Mohs,et al.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.

[11]  T. Itil,et al.  The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. , 1998, Psychopharmacology bulletin.

[12]  N. Hoffmann,et al.  Factor structure of the SCL-90 in a psychiatric population. , 1978, Journal of consulting and clinical psychology.

[13]  K. Wesnes,et al.  A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. , 1991, Current medical research and opinion.

[14]  K. Wesnes,et al.  A double‐blind placebo‐controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly , 1987 .

[15]  M. Siepmann,et al.  Pharmacokinetics and Pharmacodynamics of Scopolamine after Subcutaneous Administration , 1998, Journal of clinical pharmacology.

[16]  Keith Wesnes,et al.  Oxygen administration selectively enhances cognitive performance in healthy young adults: a placebo-controlled double-blind crossover study , 1998, Psychopharmacology.

[17]  D. Warburton [Clinical psychopharmacology of Ginkgo biloba extract]. , 1986, Presse medicale.

[18]  J. Kleijnen,et al.  Ginkgo biloba for cerebral insufficiency. , 1992, British journal of clinical pharmacology.

[19]  A. Baranov Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature. , 1982, Journal of ethnopharmacology.

[20]  K. Wesnes,et al.  The cognitive, subjective, and physical effects of a ginkgo biloba/panax ginseng combination in healthy volunteers with neurasthenic complaints. , 1997, Psychopharmacology bulletin.

[21]  R. Ihl,et al.  Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. , 1998, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[22]  A. Schatzberg,et al.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. , 1997, JAMA.

[23]  K. Wesnes,et al.  Validity and utility of the cognitive drug research (CDR) computerised cognitive testing system: A review following fifteen years of usage , 1999, European Neuropsychopharmacology.

[24]  M. Lorr,et al.  Manual for the Profile of Mood States , 1971 .

[25]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .